619
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Long-term Variability of Desmosine/Isodesmosine as Biomarker in Alpha-1-antritrypsin Deficiency–related COPD

, , , , &
Pages 329-333 | Published online: 27 Jul 2011

REFERENCES

  • Chrzanowski P, Keller S, Cerreta J, Mandl I, Turino GM. Elastin content of normal and emphysematous lung parenchyma. Am J Med 1980; 69:351–359.
  • Damiano VV, Tsang A, Kucich U, Abrams WR, Rosenbloom J, Kimbel P, Fallahnejad, M, Weinbaum G. Immunolocalization of elastase in human emphysematous lungs. J Clin Invest 1986; 78:482–493.
  • Hubbard RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med 1989; 111:206–212.
  • Rosenbloom J. Biochemical/immunologic markers of emphysema. Ann NY Acad Sci 1991; 624:7–12.
  • Foster JA, Curtiss SW. The regulation of lung elastin synthesis. Am J Physiol 1990; 259:L13–L23.
  • Stone PJ, Gottlieb DJ, O'Connor GT. Elastin and collagen degradation products in urine of smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:952–959.
  • Viglio S, Iadarola P, Lupi A, Trisolini R, Tinelli C, Balbi B, Grassi V, Worlitzsch D, Döring G, Meloni F, Meyer KC, Dowson L, Hill SL, Stockley RA, Luisetti M. MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients. Eur Respir J 2000; 15:1039–1045.
  • Ma S, Lin YY, Turino GM. Measurement of desmosine and isodesmosine by mass spectrometry in COPD. Chest 2007; 131:1363–1371.
  • Bode DC, Pagani ED, Cumiskey WR, von Roemeling R, Hamel L, Silver PJ. Comparison of urinary desmosine excretion in patients with chronic obstructive pulmonary disease or cystic fibrosis. Pulm Pharmacol Ther 2000; 13:175–180.
  • Luisetti M, Ma S, Iadarola P, Stone PJ, Viglio S, Casado B, Lin YY, Snider GL, Turino GM. Desmosine as biomarker of elastin degradation in COPD: current status and future directions. Eur Respir J 2008; 32:1146–1157.
  • Gottlieb DJ, Luisetti M, Stone PJ, Allegra L, Cantey-Kiser JM, Grassi C, Snider GL. Short-term supplementation therapy does not affect elastin degradation in severe1-antitrypsin deficiency. The American–Italian AATD Study Group. Am J Respir Crit Care Med 2000; 162:2069–2072.
  • Stoller JK, Rouhani F, Brantly M, Shahin S, Dweik RA, Stocks JM, Clausen J, Campbell E, Norton F. Biochemical efficacy and safety of a new pooled human plasma1-antitrypsin, Respitin. Chest 2002; 122:66–74.
  • Stockley RA, Luisetti M, Miravitlles M, Piitulainen E, Fernandez P; Alpha One International Registry (AIR) group. Ongoing research in Europe: Alpha One International Registry (AIR) objectives and development. Eur Respir J 2007; 29:582–586.
  • Annovazzi L, Viglio S, Perani E, Luisetti M, Baraniuk J, Casado B, Cetta G, Iadarola P. Capillary electrophoresis with laser-induced fluorescence detection as a novel sensitive approach for the analysis of desmosines in real samples. Electrophoresis 2004; 25:683–691.
  • Jones PW, Agusti AG. Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 2006; 27:822–832.
  • Stockley RA. Biomarkers in COPD: time for a deep breath. Thorax 2007; 62:657–660.
  • Gottlieb DJ, Stone PJ, Sparrow D, Gale ME, Weiss ST, Snider GL, O'Connor GT. Urinary desmosine excretion in smokers with and without rapid decline of lung function: the Normative Aging Study. Am J Respir Crit Care Med 1996; 154:1290–1295.
  • Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:367–370.
  • Laguna TA, Wagner BD, Luckey HK, Mann SA, Sagel SD, Regelmann W, Accurso FJ. Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis. Chest. 2009; 136:1561–1568.
  • Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, Nishimura K, Itoh H, Paré PD, Hogg JC, Mishima M. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 2000; 162:1102–1108.
  • Makita H, Nasuhara Y, Nagai K, Ito Y, Hasegawa M, Betsuyaku T, Onodera Y, Nizawa N, Nishimura M, and the Hokkaido COPD Cohort Study Group. Characterization of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax 2007; 62:932–937.
  • Baldi S, Miniati M, Bellina CR, Battolla L, Catapano G, Begliomini E, Giustini D, Giuntini C. Relationship between extent of pulmonary emphysema by high-resolution computed tomography and lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164:585–589.
  • Tomashefski JF, Crystal RG, Wiedemann HP, Mascha E, Stoller JK; Alpha-1 Antitrypsin Deficiency Registry Study Group. The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol 2004; 35:1452–1461.
  • Stolk J, Veldhuisen B, Annovazzi L, Zanone C, Versteeg EM, van Kuppevelt TH, Berden JH, Nieuwenhuizen W, Iadarola P, Luisetti M. Short-term variability of biomarkers of proteinase activity in patients with emphysema associated with type Z1-antitrypsin deficiency. Respir Res 2005; 6:47.
  • Viglio S, Annovazzi L, Luisetti M, Stolk J, Casado B, Iadarola P. Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. J Sep Sci 2007; 30: 202–213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.